Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development

Y. M. Sung, G. He, D. H. Hwang, S. M. Fischer

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

We previously showed that the EP2 knockout mice were resistant to chemically induced skin carcinogenesis. The purpose of this study was to investigate the role of the overexpression of the EP2 receptor in mouse skin carcinogenesis. To determine the effect of overexpression of EP2, we used EP2 transgenic (TG) mice and wild-type (WT) mice in a DMBA (7,12- dimethylbenz[α]anthracene)/TPA (12-O-tetradecanoylphorbol-13-acetate) two-stage carcinogenesis protocol. EP2 TG mice developed significantly more tumors compared with WT mice. Overexpression of the EP2 receptor increased TPA-induced keratinocyte proliferation both in vivo and in vitro. In addition, the epidermis of EP2 TG mice 48 h after topical TPA treatment was significantly thicker compared to that of WT mice. EP2 TG mice showed significantly increased cyclic adenosine monophosphate levels in the epidermis after prostaglandin E2 (PGE2) treatment. The inflammatory response to TPA was increased in EP2 TG mice, as demonstrated by an increased number of macrophages in the dermis. Tumors and 7 × TPA-treated and DMBA-TPA-treated (6 weeks) skins from EP2 TG mice produced more blood vessels than those of WT mice as determined by CD-31 immunostaining. Vascular endothelial growth factor (VEGF) protein expression was significantly increased in squamous cell carcinoma (SCC) samples from EP2 TG mice compared that of WT mice. There was, however, no difference in the number of apoptotic cells in tumors from WT and EP2 TG mice. Together, our results suggest that the overexpression of the EP2 receptor plays a significant role in the protumorigenic action of PGE2 in mouse skin.

Original languageEnglish (US)
Pages (from-to)5507-5516
Number of pages10
JournalOncogene
Volume25
Issue number40
DOIs
StatePublished - Sep 7 2006

Fingerprint

Prostaglandin Receptors
Dinoprostone
Transgenic Mice
Skin
Neoplasms
9,10-Dimethyl-1,2-benzanthracene
Carcinogenesis
Epidermis
Tetradecanoylphorbol Acetate
Dermis
Keratinocytes
Knockout Mice
Cyclic AMP
Vascular Endothelial Growth Factor A
Blood Vessels
Squamous Cell Carcinoma
Cell Count
Macrophages

Keywords

  • Angiogenesis
  • EP2 transgenic mice
  • Proliferation
  • Prostaglandin E2
  • Skin carcinogenesis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. / Sung, Y. M.; He, G.; Hwang, D. H.; Fischer, S. M.

In: Oncogene, Vol. 25, No. 40, 07.09.2006, p. 5507-5516.

Research output: Contribution to journalArticle

Sung, Y. M. ; He, G. ; Hwang, D. H. ; Fischer, S. M. / Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. In: Oncogene. 2006 ; Vol. 25, No. 40. pp. 5507-5516.
@article{0477007ede2741429892a2b74ac5bcbc,
title = "Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development",
abstract = "We previously showed that the EP2 knockout mice were resistant to chemically induced skin carcinogenesis. The purpose of this study was to investigate the role of the overexpression of the EP2 receptor in mouse skin carcinogenesis. To determine the effect of overexpression of EP2, we used EP2 transgenic (TG) mice and wild-type (WT) mice in a DMBA (7,12- dimethylbenz[α]anthracene)/TPA (12-O-tetradecanoylphorbol-13-acetate) two-stage carcinogenesis protocol. EP2 TG mice developed significantly more tumors compared with WT mice. Overexpression of the EP2 receptor increased TPA-induced keratinocyte proliferation both in vivo and in vitro. In addition, the epidermis of EP2 TG mice 48 h after topical TPA treatment was significantly thicker compared to that of WT mice. EP2 TG mice showed significantly increased cyclic adenosine monophosphate levels in the epidermis after prostaglandin E2 (PGE2) treatment. The inflammatory response to TPA was increased in EP2 TG mice, as demonstrated by an increased number of macrophages in the dermis. Tumors and 7 × TPA-treated and DMBA-TPA-treated (6 weeks) skins from EP2 TG mice produced more blood vessels than those of WT mice as determined by CD-31 immunostaining. Vascular endothelial growth factor (VEGF) protein expression was significantly increased in squamous cell carcinoma (SCC) samples from EP2 TG mice compared that of WT mice. There was, however, no difference in the number of apoptotic cells in tumors from WT and EP2 TG mice. Together, our results suggest that the overexpression of the EP2 receptor plays a significant role in the protumorigenic action of PGE2 in mouse skin.",
keywords = "Angiogenesis, EP2 transgenic mice, Proliferation, Prostaglandin E2, Skin carcinogenesis",
author = "Sung, {Y. M.} and G. He and Hwang, {D. H.} and Fischer, {S. M.}",
year = "2006",
month = "9",
day = "7",
doi = "10.1038/sj.onc.1209538",
language = "English (US)",
volume = "25",
pages = "5507--5516",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "40",

}

TY - JOUR

T1 - Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development

AU - Sung, Y. M.

AU - He, G.

AU - Hwang, D. H.

AU - Fischer, S. M.

PY - 2006/9/7

Y1 - 2006/9/7

N2 - We previously showed that the EP2 knockout mice were resistant to chemically induced skin carcinogenesis. The purpose of this study was to investigate the role of the overexpression of the EP2 receptor in mouse skin carcinogenesis. To determine the effect of overexpression of EP2, we used EP2 transgenic (TG) mice and wild-type (WT) mice in a DMBA (7,12- dimethylbenz[α]anthracene)/TPA (12-O-tetradecanoylphorbol-13-acetate) two-stage carcinogenesis protocol. EP2 TG mice developed significantly more tumors compared with WT mice. Overexpression of the EP2 receptor increased TPA-induced keratinocyte proliferation both in vivo and in vitro. In addition, the epidermis of EP2 TG mice 48 h after topical TPA treatment was significantly thicker compared to that of WT mice. EP2 TG mice showed significantly increased cyclic adenosine monophosphate levels in the epidermis after prostaglandin E2 (PGE2) treatment. The inflammatory response to TPA was increased in EP2 TG mice, as demonstrated by an increased number of macrophages in the dermis. Tumors and 7 × TPA-treated and DMBA-TPA-treated (6 weeks) skins from EP2 TG mice produced more blood vessels than those of WT mice as determined by CD-31 immunostaining. Vascular endothelial growth factor (VEGF) protein expression was significantly increased in squamous cell carcinoma (SCC) samples from EP2 TG mice compared that of WT mice. There was, however, no difference in the number of apoptotic cells in tumors from WT and EP2 TG mice. Together, our results suggest that the overexpression of the EP2 receptor plays a significant role in the protumorigenic action of PGE2 in mouse skin.

AB - We previously showed that the EP2 knockout mice were resistant to chemically induced skin carcinogenesis. The purpose of this study was to investigate the role of the overexpression of the EP2 receptor in mouse skin carcinogenesis. To determine the effect of overexpression of EP2, we used EP2 transgenic (TG) mice and wild-type (WT) mice in a DMBA (7,12- dimethylbenz[α]anthracene)/TPA (12-O-tetradecanoylphorbol-13-acetate) two-stage carcinogenesis protocol. EP2 TG mice developed significantly more tumors compared with WT mice. Overexpression of the EP2 receptor increased TPA-induced keratinocyte proliferation both in vivo and in vitro. In addition, the epidermis of EP2 TG mice 48 h after topical TPA treatment was significantly thicker compared to that of WT mice. EP2 TG mice showed significantly increased cyclic adenosine monophosphate levels in the epidermis after prostaglandin E2 (PGE2) treatment. The inflammatory response to TPA was increased in EP2 TG mice, as demonstrated by an increased number of macrophages in the dermis. Tumors and 7 × TPA-treated and DMBA-TPA-treated (6 weeks) skins from EP2 TG mice produced more blood vessels than those of WT mice as determined by CD-31 immunostaining. Vascular endothelial growth factor (VEGF) protein expression was significantly increased in squamous cell carcinoma (SCC) samples from EP2 TG mice compared that of WT mice. There was, however, no difference in the number of apoptotic cells in tumors from WT and EP2 TG mice. Together, our results suggest that the overexpression of the EP2 receptor plays a significant role in the protumorigenic action of PGE2 in mouse skin.

KW - Angiogenesis

KW - EP2 transgenic mice

KW - Proliferation

KW - Prostaglandin E2

KW - Skin carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=33748435032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748435032&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209538

DO - 10.1038/sj.onc.1209538

M3 - Article

VL - 25

SP - 5507

EP - 5516

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 40

ER -